Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$7.35 - $13.21 $129,360 - $232,496
-17,600 Reduced 43.35%
23,000 $169,000
Q1 2023

May 12, 2023

BUY
$7.79 - $16.29 $316,274 - $661,374
40,600 New
40,600 $420,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $384M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Boulder Hill Capital Management LP Portfolio

Follow Boulder Hill Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boulder Hill Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Boulder Hill Capital Management LP with notifications on news.